Methods of treating cancer using angiogenin or an angiogenin agonist
US9839676B2 · kind B2 · utility
0Cited by
9References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 10, 2013 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | May 10, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/27
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method for treating cancer in a subject or a method of inducing an anti-tumour effect including reducing tumour volume, inhibiting or slowing tumour growth, inhibiting tumour progression, altering the metabolic activity of a tumour, inducing quiescence of a tumour, inhibiting or reducing metastasis, inhibiting or reducing tumour invasiveness, reducing tumour weight, reducing tumour neovascularisation, improving time to disease progression (TDP) and/or improving survival, the method comprising administering to the subject an effective amount of angiogenin or an angiogenin agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.